Effectiveness and Safety of minimally invasive Hematoma Removal Surgery with ultra-early small Bone Window in the Treatment of hypertensive intracerebral Hemorrhage
Objective To explore the effectiveness and safety of using ultra-early small bone window minimally invasive hematoma removal surgery for hypertensive intracerebral hemorrhage(HICH)patients.Methods A total of 94 HICH patients admitted to Yucheng County People's Hospital from June 2021 to September 2022 were selected and randomly divided into study group(n=47,minimally invasive hematoma removal surgery with ultra-early bone window)and control group(n=47,conventional craniotomy hematoma removal surgery)using a random number table method.The clinical efficacy,menstrual function,oxidative stress indicators,and incidence of complications were compared between the two groups.Results The effective rate of treatment in the study group(93.62%)was higher than that in the control group(78.72%),and the difference was statistically significant(P<0.05);Compared with preoperative,the National Institutes of Health Stroke Scale(NIHSS)scores of both groups decreased after surgery,and the difference was statistically significant(P<0.05);The postoperative NIHSS score in the study group was lower than that in the control group,and the difference was statistically significant(P<0.05);After surgery,the levels of superoxide dismutase(SOD)in both groups increased compared to before surgery,and the difference was statistically significant(P<0.05).The levels of malondialdehyde(MDA),lipid peroxide(LPO),and myeloperoxidase(MPO)decreased compared to before surgery,and the difference was statistically significant(P<0.05);The SOD level in the postoperative study group was higher than that in the control group,and the difference was statistically significant(P<0.05).The MDA,LPO,and MPO levels were lower than those in the control group,and the difference was statistically significant(P<0.05);The incidence of complications in the study group(8.51%)was lower than that in the control group(25.53%),and the difference was statistically significant(P<0.05).Conclusion Minimally invasive hematoma removal surgery with ultra-early bone window for the treatment of HICH can improve clinical efficacy,improve neurological function and oxidative stress indicators,and reduce the incidence of complications.
hypertensive intracerebral hemorrhageminimally invasive hematoma removal surgery with ultra-early bone windoweffectivenesssecurity